The TfR1 protein level in the preclinical plasma of BC patients was different from that in matching controls, and TfR1 may be a novel plasma protein biomarker for ER-positive/PR-positive invasive ductal carcinoma [24]. This evidence concerns the gene ESR1 and breast cancer.